NUVB

Up next

Next earnings call

Jul 23, 2026 Est · unconfirmed · in 2 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed May 4, 2026

Equibles Rating blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Buy Momentum Weak Sentiment Bearish Fundamentals Excellent Quant / Vol Very High

Market backdrop VIX 15 · calm Equity put/call 0.55

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +6%

above

Price vs 50-day avg +15%

above

RSI (14) 56

neutral

MACD trend Positive

52-week position 49%

mid-range

Momentum

relative strength

Weak

1-month return +27%

trailing

6-month return −5%

trailing

YTD return −35%

this year

Relative strength −14%

vs S&P · 6-mo

Sentiment

smart money

Bearish

Trend (MA cross) No cross

50d $5 › 200d $5 — 200d above 50d

Institutional flow Distributing

6 of 232 funds reported for Jun 30 · net -111.1K sh shares

Insider flow Distributing

Net -$317.0K over 90 days · 67% sells

Short interest Rising

15.61% of float · ▲ +11.1% MoM · 4.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

232 holders — near 3-yr high, broad support

Squeeze score 80

high risk · 0–100

Fundamentals

Excellent

Revenue growth +699%

Y/Y

Gross margin 1%

expanding

EPS growth +72%

Y/Y

Balance sheet $116.9M

net cash

Quant / Vol

risk profile

Very High

Volatility 88%

annualized · 1-yr

Max drawdown −58%

past year

ATR 6.9%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy

0 · 3 · 3

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+6% Bullish

Price vs 50-day avg

+15% Bullish

RSI (14)

56 Neutral

MACD trend

Positive Bullish

52-week position

49% Neutral

Market signals — smart money & positioning

Bearish · 3 of 6

Trend (MA cross) No cross

50d $5 › 200d $5 — 200d above 50d

Institutional flow Distributing

6 of 232 funds reported for Jun 30 · net -111.1K sh shares

Insider flow Distributing

Net -$317.0K over 90 days · 67% sells

Short interest Rising

15.61% of float · ▲ +11.1% MoM · 4.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

232 holders — near 3-yr high, broad support

Price context

position in its 52-week range

52-wk low $2 Now $6 · 49% 52-wk high $10

vs 200-day avg +6% vs 50-day avg +15%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings

Metric	Latest	Period	YoY
net product revenues for IBTROZI	$18.5M	Q1 2026	—
cash, cash equivalents, and marketable securities	$529.2M	as of December 31, 2025	—
IBTROZI net product revenue	$24.7M	since launch	—

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Biotechnology — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
NUVB Nuvation Bio Inc. this stock	$2.02B	-35.2%	+699.0%	—	15.6%
ONC BeOne Medicines Ltd.	$431.70B	-1.7%	+22179.2%	878.5	0.1%
VRTX Vertex Pharmaceuticals Inc / Ma	$123.19B	+7.1%	+46.2%	28.8	1.9%
REGN Regeneron Pharmaceuticals, Inc.	$69.67B	-13.8%	+20.8%	16.2	3.3%
ARGX Argenx SE	$54.85B	+4.4%	—	—	2.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

231

% held: 63.1%
Reported: 6 of 232
Top holder: FMR LLC

Held Float

View

Held by Funds

Fund positions

179

View

Short & Settlement

Short Interest Rising

Shares short

54.4M

Days to cover: 4.6d
Change: +5.4M sh

View

Short Volume

Short vol %

73%

As of: Jul 10, 2026

Short Total

View

Fails to Deliver

FTD shares

17.2K

Value: $82.7K
As of: Jun 9, 2026

View

Off-Exchange

Off-exchange %

48.5%

Week of: May 4, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$317.0K

Buyers / Sellers: 1 / 2

Buyers Sellers

View

Financials

Revenue (FY)

$62.9M

Net income (FY): $-204.6M
EPS diluted: $-0.60

View

Filings

SEC Filings

Latest

8-K

Filed: Jul 6, 2026
This year: 11

View

Proposed Sales

Value

$274.6K

Shares: 47.7K
Filed: Jun 23, 2026

View

Earnings & Events

Earnings Calls

Last call

Jun 3, 2026

View

Investor Relations

	5D	20D	120D	MTD	YTD
NUVB	+1.9%	+26.9%	-5.4%	+2.3%	-35.2%
SPY	+1.4%	+4.1%	+9.1%	+1.1%	+10.7%
vs SPY	+0.6%	+22.8%	-14.4%	+1.2%	-45.9%

Price & Indicators

Technicals

Key metrics

Versus peers

At a glance

Performance